Pure Global
NCT05354466

Perioperative Respiratory Adverse events_sugammadex

Effect of Sugammadex Versus Neostigmine on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: a Randomized Controlled Trial
Seoul National University Hospital·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Respiratory Complication
Drug/Device/Intervention
Sugammadex injection
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Seoul National University Hospital
Location
Seoul, South Korea
Timeline & enrollment
Phase
N/A
Start date
Jun 27, 2022
End date
Dec 31, 2023
Enrollment
174 participants
Primary outcome

Perioperative respiratory adverse events

Summary

Perioperative respiratory adverse events are common in children. We aimed to evaluate the
 effect of sugammadex on the incidence of perioperative respiratory adverse events in
 pediatric patients receiving tonsillectomy

ICD-10 classifications
Respiratory disorder, unspecifiedOther respiratory disordersRespiratory failure, unspecifiedOther postprocedural respiratory disordersOther specified respiratory disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05354466
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05354466 through Pure Global AI's free database. This phase not specified trial is sponsored by Seoul National University Hospital and is currently Recruiting. The study focuses on Respiratory Complication. Target enrollment is 174 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.